Generic medicine

Brimonidine Tartrate 0.2% w/v Eye Drops

Reviewed educational reference: what Brimonidine Tartrate is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Brimonidine Tartrate
Strength
0.2% w/v
Dosage form
Eye Drops
Drug class
Alpha-2 adrenergic agonist

Related products

No reviewed products are currently published for this generic.

Brimonidine Tartrate 0.2% w/v Eye Drops contains Brimonidine Tartrate, a selective alpha-2 adrenergic receptor agonist used primarily to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. By reducing the production of aqueous humor and increasing its outflow, Brimonidine Tartrate 0.2% w/v Eye Drops helps prevent optic nerve damage and vision loss associated with high eye pressure.

At a glance

Quick look

Brimonidine Tartrate 0.2% w/v Eye Drops is a 0.2% ophthalmic solution of Brimonidine Tartrate.

How it works

It works by reducing aqueous humor production and increasing its outflow.

Who it is for

It is used to treat open-angle glaucoma and ocular hypertension.

Uses it for
Open-angle glaucomaOcular hypertensionIOP reductionAdjunctive therapyPost-surgical careOptic nerve protection

Uses of Brimonidine Tartrate

  • Reduction of elevated intraocular pressure in open-angle glaucoma
  • Management of ocular hypertension
  • Adjunctive therapy for patients who do not respond to beta-blockers
  • Post-surgical pressure control
  • Long-term maintenance of stable intraocular pressure
  • Reduction of risk of optic nerve atrophy

Benefits of Brimonidine Tartrate

Effective Pressure Control
The primary benefit of Brimonidine Tartrate 0.2% w/v Eye Drops is its ability to significantly lower intraocular pressure. By targeting alpha-2 receptors, it provides a dual mechanism of action that decreases the inflow of fluid into the eye while simultaneously enhancing the uveoscleral outflow, ensuring a more stable ocular environment.

Alternative to Beta-Blockers
Many patients cannot tolerate beta-blocker eye drops due to systemic side effects like bradycardia or bronchospasm. Brimonidine Tartrate 0.2% w/v Eye Drops serves as a highly effective alternative for these individuals, offering potent IOP reduction without the systemic cardiovascular or respiratory risks commonly associated with non-selective beta-adrenergic antagonists.

Side effects of Brimonidine Tartrate

Common side effects of Brimonidine Tartrate 0.2% w/v Eye Drops include ocular hyperemia (redness of the eye), stinging or burning sensations upon instillation, and a feeling of having a foreign body in the eye. Some patients may experience blurred vision, dryness, or itching. Systemic side effects are less common but can include fatigue, headache, drowsiness, and dry mouth. In rare instances, patients may develop allergic conjunctivitis or follicular conjunctivitis. If you experience severe eye pain, vision loss, or signs of a severe allergic reaction such as swelling of the face or difficulty breathing, seek medical attention immediately. Most local ocular side effects are transient and tend to diminish as the eye adjusts to the medication over time.

Side effectHow commonHow severeWhat to do
Ocular HyperemiaVery commonMildUsually resolves with continued use.
DrowsinessCommonModerateAvoid driving or operating machinery.
Dry MouthCommonMildIncrease water intake.

How to manage side effects

Ocular Hyperemia

  • Monitor for persistent redness.
  • Consult a doctor if pain occurs.
  • Ensure proper instillation technique.

Drowsiness

  • Assess the severity of fatigue.
  • Consider dose timing.
  • Report to the physician if it impacts daily life.

Dry Mouth

  • Maintain good oral hygiene.
  • Use sugar-free gum if necessary.
  • Monitor for persistent discomfort.

How to use Brimonidine Tartrate

  • Wash your hands thoroughly before handling the dropper bottle.
  • Tilt your head back and pull down your lower eyelid to create a small pocket.
  • Hold the dropper above the eye and squeeze one drop into the pocket.
  • Close your eye gently and press your finger against the inner corner of the eye for one minute.
  • Do not touch the tip of the dropper to your eye, eyelid, or any other surface to prevent contamination.
  • Wait at least 15 minutes before inserting contact lenses if you wear them.

Special population advice

Kidney impairment

  • Monitor systemic blood pressure closely.
  • Use the lowest effective dose.

Liver impairment

  • Use with caution.
  • Monitor for systemic side effects.

Children

  • Contraindicated in children under 2 years.
  • Use with extreme caution in older children.

Elderly

  • Monitor for orthostatic hypotension.
  • Observe for increased sensitivity to CNS effects.

How Brimonidine Tartrate works

Brimonidine Tartrate acts as a selective alpha-2 adrenergic agonist. It reduces the production of aqueous humor by the ciliary body and enhances the uveoscleral outflow of the fluid. This dual action effectively lowers the intraocular pressure, which is the primary risk factor for glaucomatous optic nerve damage.

What if you miss or exceed a dose?

If you miss a dose

If you miss a dose of Brimonidine Tartrate 0.2% w/v Eye Drops, apply it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular routine. Do not apply two doses at the same time to make up for a forgotten one.

In case of overdose

Overdose with Brimonidine Tartrate 0.2% w/v Eye Drops is rare when used as directed. If accidental ingestion occurs, especially in children, symptoms may include hypotension, bradycardia, hypothermia, lethargy, and respiratory depression. Seek emergency medical help immediately if a large amount is swallowed or if systemic symptoms appear after eye drop use.

AntidoteNo specific antidote.

Treatment is symptomatic and supportive.

Supportive Care
Maintain airway and monitor vital signs.
Hypotension
Manage with fluids or vasopressors if necessary.
Bradycardia
Atropine may be considered if symptomatic.
Observation
Monitor the patient for several hours until stable.

Safety and precautions

When to avoid Brimonidine Tartrate

Do not take if you
  • Hypersensitivity

    Do not use if allergic to brimonidine or any ingredients.

  • MAO Inhibitor therapy

    Contraindicated in patients receiving monoamine oxidase inhibitor therapy.

Use with caution
  • Cardiovascular disease

    Use with caution in patients with severe heart disease.

  • Depression

    May exacerbate symptoms of depression.

  • Cerebral insufficiency

    Use with caution in patients with impaired blood flow to the brain.

  • Raynaud's phenomenon

    May worsen symptoms of vascular insufficiency.

Safety at a glance

AlcoholUse with caution

Alcohol may increase the sedative effects of the medication.

PregnancyConsult your doctor

Use only if the potential benefit justifies the risk to the fetus.

BreastfeedingConsult your doctor

Consult your doctor as it is unknown if the drug passes into breast milk.

DrivingUse with caution

May cause drowsiness or blurred vision; do not drive if affected.

KidneyUse with caution

Use with caution in patients with severe renal impairment.

LiverUse with caution

Use with caution in patients with hepatic impairment.

AllergyUnsafe

Do not use if you have a known allergy to brimonidine.

ChildrenUnsafe

Not recommended for children under 2 years of age due to risk of apnea.

ElderlyUse with caution

Use with caution as elderly patients may be more sensitive to systemic effects.

Interactions

With other medicines

Beta-blockers

Moderate

Changes the medicine’s effect

What can happen: Additive reduction in blood pressure.

What to do: Monitor heart rate and blood pressure regularly.

CNS Depressants

Moderate

Changes the medicine’s effect

What can happen: Increased sedation.

What to do: Avoid alcohol and other sedatives while on therapy.

MAO Inhibitors

Major

Changes how the medicine is processed

What can happen: Potential for hypertensive crisis.

What to do: Avoid concurrent use; consult a specialist.

With food and drink

  • AlcoholModerate

    May potentiate central nervous system depression and cause increased drowsiness or dizziness.

  • CaffeineMinor

    High caffeine intake can potentially counteract the blood pressure lowering or calming systemic effects.

If you have another condition

  • Cardiovascular disease

    May cause fluctuations in blood pressure or heart rate.

  • Renal/Hepatic impairment

    Requires careful monitoring due to potential systemic accumulation.

Quick tips

  • Always store the bottle in an upright position in a cool, dry place.
  • Remove contact lenses before using the drops and wait 15 minutes before re-inserting.
  • If you use multiple types of eye drops, wait at least 5 to 10 minutes between each medication.
  • Inform your doctor if you have a history of heart disease, depression, or blood pressure issues.
  • Do not use the medication if the seal on the bottle is broken or if the solution appears cloudy.
  • Regular eye check-ups are essential to monitor the effectiveness of the treatment.

Counselling points

  • TechniqueImportant

    Ensure the dropper tip does not touch the eye to avoid contamination.

  • Contact LensesImportant

    Wait 15 minutes after application before inserting contact lenses.

  • Systemic effectsGood to know

    Report any dizziness or unusual fatigue to your doctor.

  • ConsistencyGood to know

    Use the drops at the same time every day for best results.

Monitoring during treatment

Before starting

  • Intraocular pressure measurement
  • Baseline blood pressure
  • Visual field assessment

During treatment

  • every 3 months: Repeat intraocular pressure and visual field tests

What is being watched

  • Intraocular pressure
  • Blood pressure
  • Heart rate
  • Visual acuity

Pharmacokinetics

Absorption
Systemic absorption is low following ocular administration.
Bioavailability
Not applicable for topical ocular use.
Protein binding
Approximately 29%.
Volume of distribution
Not established.
Half-life
Approximately 3 hours in plasma.
Metabolism
Extensively metabolized by the liver.
Excretion
Primarily excreted in urine as metabolites.
Onset / duration
Onset within 1-2 hours; duration 8-12 hours.

Fact box

Chemical class
Quinoxaline derivative
Habit forming
No
Therapeutic class
Antiglaucoma agent
Action class
Ocular hypotensive
Storage
Store at room temperature between 15°C and 25°C. Keep the bottle tightly closed and protected from light. Keep out of reach of children.
ATC code
S01EA05
Pregnancy category
B

More information

Clinical Rationale for Selection

Clinicians often select Brimonidine Tartrate as a first-line or second-line agent for patients who have contraindications to beta-blockers, such as those with asthma, chronic obstructive pulmonary disease, or bradycardia. Unlike beta-blockers, which can cause systemic bronchoconstriction or heart rate reduction, Brimonidine Tartrate provides a targeted approach to lowering intraocular pressure with a lower risk of pulmonary side effects. Its ability to both decrease aqueous humor production and increase uveoscleral outflow makes it a versatile tool in the management of chronic open-angle glaucoma, particularly when monotherapy with prostaglandin analogs is insufficient or not tolerated.

Comparison with Alternatives

When compared to prostaglandin analogs, Brimonidine Tartrate is often used as an adjunctive therapy rather than a primary monotherapy due to its dosing frequency. While prostaglandins are typically dosed once daily, Brimonidine Tartrate usually requires twice or thrice-daily administration. However, it is superior in patients who experience ocular surface inflammation or hyperpigmentation from prostaglandin analogs. Compared to carbonic anhydrase inhibitors, Brimonidine Tartrate is generally better tolerated by patients who experience metallic taste or systemic malaise, making it a preferred choice for long-term adherence in stable glaucoma patients.

Lifestyle and Treatment Expectations

Patients starting Brimonidine Tartrate should expect a consistent routine of eye drop application. It is important to understand that this medication does not cure glaucoma but manages the pressure to prevent further vision loss. Lifestyle adjustments include ensuring the drops are kept in a convenient place to avoid missed doses. Patients may notice mild redness initially, which usually settles within a few weeks. It is also advised to avoid activities that require sharp focus immediately after application, as the drops may cause temporary blurring. Regular follow-up appointments are critical to ensure the target intraocular pressure is maintained throughout the course of treatment.

Common Misconceptions

A frequent misconception is that eye drops for glaucoma can improve vision that has already been lost. It is vital to clarify that Brimonidine Tartrate is designed to preserve remaining vision by controlling pressure, not to restore lost visual field. Another common error is the belief that if the eye feels fine, the medication can be stopped. Glaucoma is often asymptomatic, and stopping the drops can lead to a silent, rapid increase in intraocular pressure, causing irreversible damage to the optic nerve. Patients must be educated that the absence of symptoms does not mean the disease is cured or that the medication is no longer necessary.

References

  1. Medicines.org.uk. Brimonidine Tartrate 0.2% Eye Drops, Summary of Product Characteristics.View sourceAccessed
  2. NAFDAC. Brimonidine Eye Drop Summary of Product Characteristics.View sourceAccessed
  3. DailyMed. Brimonidine Tartrate Ophthalmic Solution label.View sourceAccessed
  4. Drugs.com. Brimonidine Ophthalmic Professional Information.View sourceAccessed
  5. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed

Frequently asked questions about Brimonidine Tartrate

Can I wear contact lenses while using Brimonidine Tartrate 0.2% w/v Eye Drops?

You should remove your contact lenses before applying the drops and wait at least 15 minutes before putting them back in.

How long does it take for Brimonidine Tartrate 0.2% w/v Eye Drops to work?

The pressure-lowering effect is usually seen within 1 to 2 hours after the first dose.

Is Brimonidine Tartrate 0.2% w/v Eye Drops safe for long-term use?

Yes, it is commonly prescribed for long-term management of glaucoma, but regular monitoring by an ophthalmologist is required.

What should I do if I get eye irritation?

Mild irritation is common. If it persists or becomes severe, consult your doctor to rule out an allergic reaction.

Can I use Brimonidine Tartrate 0.2% w/v Eye Drops with other eye drops?

Yes, but you should wait at least 5 to 10 minutes between applying different types of eye drops to ensure proper absorption.

Latest